258 results
8-K
EX-10.2
SNGX
Soligenix Inc
22 Apr 24
Soligenix Announces Pricing of $4.75 Million Public Offering
4:05pm
, (ii) reimbursement for expenses incurred on behalf of the Company or a Subsidiary and (iii) other employee benefits, including share option
8-K
EX-10.1
SNGX
Soligenix Inc
22 Apr 24
Soligenix Announces Pricing of $4.75 Million Public Offering
4:05pm
Agent in connection with the Placement, provided, however, that such reimbursement for non-accountable expenses shall not exceed $15,000.
SECTION 5
8-K
EX-99.1
SNGX
Soligenix Inc
22 Apr 24
Soligenix Announces Pricing of $4.75 Million Public Offering
4:05pm
in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives
424B4
SNGX
Soligenix Inc
19 Apr 24
Prospectus supplement with pricing info
4:05pm
practice and third party reimbursement limitations.
Our product candidates may cause serious adverse events or undesirable side effects which may delay … ;
the product is not eligible for third-party reimbursement from government or private insurers;
others hold proprietary rights that preclude us from
8-K
EX-99.2
SNGX
Soligenix Inc
3 Apr 24
Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Statistically Significant Phase 3 Study
4:05pm
approvals, ability to commercialize our products and product candidates and attract collaborators, reimbursement for our product candidates, research … light unit to customers ➢ Treatment will not have large financial impact on payers; low/no barriers to access as reimbursement can occur under existing
8-K
EX-99.1
6j0vq8
3 Apr 24
Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Statistically Significant Phase 3 Study
4:05pm
8-K
EX-99.1
wzpe 7jsg395
17 Nov 23
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
4:05pm
8-K
EX-99.1
1j2q0g
20 Oct 23
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
4:05pm
8-K
EX-99.1
tzq 8ds2o3en
22 Sep 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
EX-99.2
051l0gev
9 May 23
Soligenix Announces Pricing of $8.5 Million Public Offering
4:15pm